Obagi Medical launches two new aesthetic products
The Complete Complex Serum is formulated with a bi-mineral complex and malonic acid, which in combination is shown to improve the appearance of fine lines and wrinkles around
The US Food and Drug Administration (FDA) has issued traditional approval to Novartis for Fabhalta (iptacopan), to slow the decline of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk of disease progression.
The company said recent facilities upgrades have expanded its capabilities to include commercial scale manufacturing of Schedule II controlled substances. The Schedule II controlled substances are manufactured within
The patent covers compositions of matter related to the antibody-based targeted delivery of biologically active compounds (including therapeutics) using Vaxiion’s minicell-delivery platform technology. Vaxiion’s targeted therapeutic delivery platform